The effectiveness of the combined effect of PARP and BET inhibition has been verified in different cancers.,8, 9, 10 and our previous study in ovarian cancer showed that combining the PARP inhibitor BMN673 with the BET inhibitor JQ1 resulted in a potent lethal anticancer effect.11 This evidence concerns the gene DNER and ovarian carcinoma.